Europe is facing a migrant crisis due to an influx of refugees and other migrants. Many migrants travel in unseaworthy boats owned by smugglers in a bid to escape conflict in Syria. The EU is ...

Rob & Akiva Need a Podcast Bonus Episode: How I Met Your Father — January 22, 2022 RAANAP Groundhog Week Day 1 — February 6, 2023 RAANAP Groundhog Week Day 2 — February 7, 2023 RAANAP G ...

The US Food and Drug Administration (FDA) has granted fast track designation to Pyxis Oncology’s antibody-drug conjugate (ADC), PYX-201, to treat adults with recurrent or metastatic head and ...

PYX-201 has gained FDA fast track designation in recurrent or metastatic head and neck squamous cell carcinoma. The FDA granted fast track designation to PYX-201 for the treatment of adult patients ...

"Receiving Fast Track designation for PYX-201 from the FDA marks a significant milestone for Pyxis Oncology, recognizing our potential to address the significant medical need in R/M HNSCC.

“Receiving Fast Track designation for PYX-201 from the FDA marks a significant milestone for Pyxis Oncology, recognizing our potential to address the significant medical need in R/M HNSCC. This ...

Pyxis Oncology, Inc. announced that the FDA has granted Fast Track Designation for its drug PYX-201, aimed at treating ... open market 2 times in the past 6 months. Of those trades, 2 have been ...

Pyxis Oncology (PYXS) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to PYX-201 for the treatment of adult patients with recurrent or metastatic head and ...

“Receiving Fast Track designation for PYX-201 from the FDA marks a significant milestone for Pyxis Oncology, recognizing our potential to address the significant medical need in R/M HNSC ...